Mattias Lorentzon, MD, PhD
Sahlgrenska University Hospital Mölndal, Västra Götalandsregionen and University of Gothenburg · Sahlgrenska University Hospital, Västra Götalandsregionen · Sahlgrenska University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mattias Lorentzon, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:23 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07772609 · Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMDSahlgrenska University Hospital · not yet recruiting · Osteoporosis in Post-menopausal Women · principal investigator
- N/ANCT06603545 · The Effect of Digital Education for Osteoporosis Patients on Fracture Risk and Related Health Outcomes.Sahlgrenska University Hospital · recruiting · Osteoporosis, Accidental Falls, Fractures, Bone · principal investigator
- N/ANCT04767711 · Prevention of Glucocorticoid Induced Impairment of Bone MetabolismSahlgrenska University Hospital · completed · Bone Loss · principal investigator
- N/ANCT04755686 · Effects of Fast-tracking Geriatric Hip Fracture PatientsSahlgrenska University Hospital · withdrawn · Hip Fracture · principal investigator
- N/ANCT04169789 · Prevention of Early Postmenopausal Bone Loss With Lactobacillus ReuteriSahlgrenska University Hospital · completed · Postmenopausal Osteoporosis · principal investigator
- N/ANCT02422082 · The Effect of Lactobacillus Reuteri ATCC PTA 6475 on Volumetric Bone Mineral Density in Patients With OsteopeniaSahlgrenska University Hospital · completed · Osteopenia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.